デフォルト表紙
市場調査レポート
商品コード
1467881

自己幹細胞と非幹細胞ベースの治療市場レポート:タイプ、用途、エンドユーザー、地域別、2024~2032年

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type, Application, End User, and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 137 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
自己幹細胞と非幹細胞ベースの治療市場レポート:タイプ、用途、エンドユーザー、地域別、2024~2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自己幹細胞と非幹細胞ベースの治療市場規模は、2023年に77億米ドルに達しました。IMARC Groupは、2024~2032年にかけての成長率(CAGR)は11.87%で、2032年には216億米ドルに達すると予測しています。生命を脅かす疾患の増加、高齢者人口の増加、幹細胞技術の進歩は、市場を牽引する重要な要因のひとつです。

自己幹細胞ベースの治療は、患者の幹細胞を用いて損傷した組織や臓器を修復したり、様々な疾患を治療したりする医療行為です。この治療法では、患者の体内から幹細胞を採取し、通常は骨髄や脂肪組織から採取した幹細胞を加工して体内に戻します。一方、非幹細胞を用いた治療法は、幹細胞ではない細胞、例えば免疫細胞、線維芽細胞、筋肉細胞などを用いて、損傷した組織や臓器を修復・再生するものです。自己幹細胞ベースの治療は、心血管疾患、神経変性疾患、自己免疫疾患の治療に用いられ、非幹細胞ベースの治療は、慢性創傷、心臓病、パーキンソン病の治療に用いられています。

自己幹細胞と非幹細胞ベースの治療市場動向:

自己幹細胞と非幹細胞ベースの治療の世界市場の成長は、主に消費者の喫煙、食生活の乱れ、座りっぱなしのライフスタイルによる、がん、糖尿病、心血管障害、神経変性疾患の有病率の増加が牽引しています。これに加えて、高齢者人口の増加と自己幹細胞と非幹細胞ベースの治療に対する需要の高まりが、市場に明るい展望をもたらしています。さらに、再生医療を目指した革新的な自己幹細胞ベースの治療の市場開拓が進んでおり、個別化治療への需要が広がっていることも、市場に有益な成長機会をもたらしています。これに加えて、低侵襲治療の人気の高まり、幹細胞ベースの治療の受容の拡大、幹細胞研究に対する財政的・規制的支援のような政府の好意的なイニシアチブの実施が、市場の拡大を後押ししています。さらに、幹細胞技術の絶え間ない進歩により、研究開発者は幹細胞の分化をよりうまくコントロールできるようになり、より改善された効果的な治療法を開発できるようになりました。この他にも、医療セグメントの成長促進、広範な研究開発活動、消費者の健康意識の高まり、有利な償還政策などが市場成長に寄与しています。

本レポートで扱う主要質問

  • 世界の自己幹細胞と非幹細胞ベースの治療市場はこれまでどのように推移してきたのか?
  • 世界の自己幹細胞と非幹細胞ベースの治療市場における市場の促進要因、抑制要因、機会は何か?
  • それぞれの促進要因、抑制要因、機会が世界の自己幹細胞と非幹細胞ベースの治療市場に与える影響は?
  • 主要な地域市場とは?
  • 最も魅力的な自己幹細胞と非幹細胞ベースの治療市場はどの国ですか?
  • タイプ別の市場内訳は?
  • 自己幹細胞と非幹細胞ベースの治療市場で最も魅力的なタイプは?
  • 用途別の市場内訳は?
  • 自己幹細胞と非幹細胞ベースの治療市場において、最も魅力的な用途はどれですか?
  • エンドユーザー別の市場内訳は?
  • 自己幹細胞と非幹細胞ベースの治療市場において最も魅力的なエンドユーザーは?
  • 世界の自己幹細胞と非幹細胞ベースの治療市場の競合構造は?
  • 世界の自己幹細胞と非幹細胞ベースの治療市場における主要参入企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 自己幹細胞と非幹細胞ベースの治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:タイプ別

  • 自己幹細胞
  • 非自己幹細胞

第7章 市場内訳:用途別

  • がん
  • 神経変性疾患
  • 心血管疾患
  • 整形外科疾患
  • その他

第8章 市場内訳:エンドユーザー別

  • 病院
  • 外来手術センター
  • 調査施設

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BrainStorm Cell Limited
    • Cytori Therapeutics Inc.
    • Holostem Terapie Avanzate S.r.l.
    • Lisata Therapeutics
    • U.S. Stem Cell Inc.
図表

List of Figures

  • Figure 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Major Drivers and Challenges
  • Figure 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Value Chain Analysis
  • Figure 79: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Competitive Structure
  • Table 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Players
目次
Product Code: SR112024A7527

The global autologous stem cell and non-stem cell based therapies market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.6 Billion by 2032, exhibiting a growth rate (CAGR) of 11.87% during 2024-2032. The increasing prevalence of life-threatening diseases, the expanding geriatric population, and ongoing advancements in stem cell technologies represent some of the key factors driving the market.

Autologous stem cell therapy is a medical procedure in which a patient's stem cells are used to repair damaged tissues and organs or treat various diseases. The procedure involves harvesting stem cells from a patient's body, usually from bone marrow or adipose tissue, and then processing and injecting them back into the body. Non-stem cell-based therapies, on the other hand, involve using cells that are not stem cells, such as immune cells, fibroblasts, and muscle cells, to repair or regenerate damaged tissues or organs. Autologous stem cell therapy is used to treat cardiovascular diseases, neurodegenerative diseases, and autoimmune disorders, while non-stem cell-based therapies are employed in treating chronic wounds, heart disease, and Parkinson's disease.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends:

The growth of the global autologous stem cell and non-stem cell based therapies market is primarily driven by the increasing prevalence of cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases due to smoking, poor diet, and sedentary lifestyles of consumers. Besides this, the rising geriatric population and the growing demand for autologous stem and non-stem cell based therapies are creating a positive outlook for the market. Moreover, the ongoing development of innovative autologous stem cell therapies for regenerative medicine and the widespread demand for personalized therapies are presenting remunerative growth opportunities for the market. In addition to this, the surging popularity of minimally invasive treatments, the expanding acceptance of stem cell therapies, and the implementation of favorable government initiatives, such as financial and regulatory support for stem cell research, are aiding in market expansion. Furthermore, continuous advancements in stem cell technologies have enabled researchers to better control the differentiation of stem cells and develop improved and effective treatments, which, in turn, is acting as a significant growth-inducing factor. Besides this, the bolstering growth of the healthcare sector, extensive research and development (R&D) activities, the escalating health consciousness among consumers, and favorable reimbursement policies are contributing to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global autologous stem cell and non-stem cell based therapies market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.

Type Insights:

Autologous Stem Cells

Autologous Non-Stem Cells

The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the type. This includes autologous stem cells and autologous non-stem cells. According to the report, autologous stem cells represented the largest segment.

Application Insights:

Cancer

Neurodegenerative Disorders

Cardiovascular Disease

Orthopedic Diseases

Others

A detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the application has also been provided in the report. This includes cancer, neurodegenerative disorders, cardiovascular disease, orthopedic diseases, and others. According to the report, cancer accounted for the largest market share.

End User Insights:

Hospitals

Ambulatory Surgical Centers

Research Facilities

The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the end user. This includes hospitals, ambulatory surgical centers, and research facilities. According to the report, hospitals represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for autologous stem cell and non-stem cell based therapies. Some of the factors driving the North America autologous stem cell and non-stem cell based therapies market included the expanding prevalence of chronic diseases, the rising demand for personalized medicines, and continuous advancements in stem cell technologies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global autologous stem cell and non-stem cell based therapies market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BrainStorm Cell Limited, Cytori Therapeutics Inc., Holostem Terapie Avanzate S.r.l., Lisata Therapeutics, U.S. Stem Cell Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global autologous stem cell and non-stem cell based therapies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global autologous stem cell and non-stem cell based therapies market?
  • What is the impact of each driver, restraint, and opportunity on the global autologous stem cell and non-stem cell based therapies market?
  • What are the key regional markets?
  • Which countries represent the most attractive autologous stem cell and non-stem cell based therapies market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the autologous stem cell and non-stem cell based therapies market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the autologous stem cell and non-stem cell based therapies market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the autologous stem cell and non-stem cell based therapies market?
  • What is the competitive structure of the global autologous stem cell and non-stem cell based therapies market?
  • Who are the key players/companies in the global autologous stem cell and non-stem cell based therapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Autologous Stem Cells
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Autologous Non-Stem Cells
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurodegenerative Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Disease
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Orthopedic Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Facilities
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 BrainStorm Cell Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Cytori Therapeutics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Holostem Terapie Avanzate S.r.l.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Lisata Therapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 U.S. Stem Cell Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.